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Residual Cognitive Deficit in Adults with Depression 
who Recovered after 6-month Treatment: Stable 
versus State-Dependent Markers
Charles Lung-Cheng Huanga, b, c
Abstract
Background:  Knowledge of depression-related disturbances in 
cognitive functioning is advancing, but little is known about the 
cognitive response to treatment for major depression, especially 
in younger adults. This study investigated the deficits in multiple 
cognitive domains in middle-aged patients with major depressive 
disorder (MDD), using a prospective follow-up study design.
Methods:  The sample consisted of 13 medication-free MDD pa-
tients  and  13  education-  and  age-matched  healthy  controls. All 
subjects were administered clinical measures as well as a com-
prehensive neurocognitive test battery aimed at assessing multiple 
cognitive domains at the time of recruitment. Patients remitted after 
6 months following treatment repeated the neurocognitive assess-
ment.
Results:  There were significant differences between the depressed 
subjects  and  controls  at  baseline.  MDD  patients  with  remitted 
symptoms still showed significant deficits in executive function and 
motor function, but not in memory or attention domains. Patients 
had  significant  improvement  in  memory  and  attention  domains 
only, once their depressive symptoms had subsided; while execu-
tive functioning as well as motor functioning remained unchanged.
Conclusions:  Executive functioning and motor functioning defi-
cits might be stable vulnerability indicators for MDD, and memory 
and attention impairment might serve as state-dependent indicators 
for MDD.
Keywords:  Major depressive disorder; Remission; Residual; Cog-
nitive deficits; Follow-up
Introduction
  Depression-related  disturbances  in  cognitive  func-
tion have been demonstrated in a range of domains [1, 2]. 
However, it is still unclear if the cognitive impairment is a 
state characteristic of major depressive disorder (MDD), or 
whether the cognitive deficit persists upon recovery from de-
pressive episodes. The findings across previous studies have 
varied somewhat, but suggest that a substantial proportion 
of patients with a history of depression exhibit persistent 
cognitive impairment, particularly in memory [3], attention 
[4], and executive functioning [5]. The use of testing before 
and after recovery is a potentially more powerful method of 
identifying and distinguishing state- from trait-related cogni-
tive deficits [6]. Using this design, a small number of studies 
have reported improvement in cognitive functioning, such 
as memory [7-11], attention [10], executive function [9, 11], 
and psychomotor function [9], after treatment. In contrast, 
some authors found that residual cognitive deficits involv-
ing memory [12-14], executive function [10, 13], attention 
[13, 15], and psychomotor function [10, 12], persisted upon 
clinical recovery. 
   The controversial results may due to some methodolog-
ical limitations in these longitudinal studies. For example, 
using inadequate definitions of recovery [7, 8, 15], failing to 
show that task performance was within the normal range at 
recovery [9, 11], not controlling for the potential effects of 
age and educational level [9, 11], and not controlling for the 
potential effects of medication and electroconvulsive thera-
py [9, 10, 14, 15]. In addition, the majority of these studies 
focused on elderly individuals [10-13]. Although knowledge 
of residual cognitive dysfunction in elderly MDD patients is 
increasing, significant gaps remain in our understanding of 
the cognitive response to treatment in younger adult depres-
sion.
  The present study investigated the deficits in multiple 
cognitive domains of adults with depression with a prospec-
tive follow-up, case-control design. The main objective was 
to examine whether cognitive deficits in MDD patients im-
prove with successful treatment of depression, as well as to 
determine stable versus state-dependent markers of MDD.
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Materials and Methods
   
Subjects and design
       
  This was a prospective follow-up, case-control study. 
Thirteen patients (aged 18-50 years) with a diagnosis of non-
psychotic, unipolar MDD from the DSM-IV, were recruited. 
In addition, they had scored at least 16 on the 17-item Hamil-
ton Depression Rating Scale (HAM-D-17) [16] and were en-
tirely psychotropic medication-free currently and for at least 
six weeks before recruitment. Subjects were excluded if they 
had a history of any neurological or major medical illness, or 
significant alcohol or substance abuse. Thirteen education- 
and age-matched healthy controls were recruited from the 
community by advertisement. These volunteers were inter-
viewed by a senior psychiatrist using the Chinese version 
of the Mini International Neuropsychiatric Interview (MINI) 
[17] to exclude individuals with mental illnesses. 
  Severity  of  depression  was  rated  using  the  17-item 
Hamilton  Rating  Scale  for  Depression  (HAM-D-17)  for 
all subjects. A comprehensive neurocognitive test battery, 
including the Wechsler Memory Scale-Revised (WMS-R) 
[18], Wisconsin Card Sorting Test (WCST) [19], Continu-
ous Performance Test (CPT) [20], and Finger Tapping Test 
(FTT) [21], was used to assess memory, attention, executive 
functioning, and motor functioning domains, respectively. 
The battery was administered at the time of recruitment as 
a baseline measure (assessment I). The same battery was 
used with the group of patients whose depressive symptoms 
had remitted (scoring less than 7 on the HAM-D) after six 
months of treatment (assessment II). During the follow-up 
period, patients received a standard treatment protocol with 
SSRI only. All subjects signed an informed consent state-
ment. The Ethical Committee for Human Research of local 
hospital had approved the study protocol..
 
Data analyses 
  Rates and proportion with a two-tailed 95% CI were 
calculated for the variables of interest. Cross-table chi-square 
analysis was used to compare sex, education level, and mari-
tal status of the MDD patients and healthy controls. The sig-
nificance of differences in cognitive performance between 
the two groups was calculated with the Mann-Whitney Test. 
The significance of differences in the cognitive measures of 
the MDD subjects between assessment I and assessment II 
was tested using a Wilcoxon signed ranks test. All data were 
analyzed  using  the  SPSS  for  Windows  package,  Release 
10.0.
 
Results
 The demographic profiles and HAM-D scores for the 
MDD patients and controls are shown in Table 1. The aver-
age age of the patients was 37.2 years. There was no sig-
MDD patients Normal controls
‡ Z p value
Mean ± SD N Mean ± SD N
Sex 0.69
Male 4 6
Female 9 7
Education level 0.22
Below junior high school 3 0
Above junior high school 10 13
Age 37.19 ± 12.62 13 38.92 ± 12.61 13 -0.51 0.61
† HAM-D-17 23.23 ± 6.10 13 0.38 ± 0.51 13 -4.41 < 0.01
Table 1. Demographic data and HAM-D scores for MDD patients and controls
† HAM-D-17:17-item Hamilton Rating Scale for Depression
‡ Mann-Whitney Test was used to compare the ages and HAM-D scores in both groups
Cross table chi-square was used to compare the sex and education level
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nificant difference in gender, education level, or age between 
the patients and control groups.
The  HAM-D  scores  and  neurocognitive  measures 
for the MDD patients and controls are shown in Table 2. 
Compared to the controls, the depressed patients were sig-
nificantly impaired in several cognitive domains, including 
memory (as measured by the WMS-R), executive function 
(as measured by the WCST), motor function (as measured 
by the FTT), and attention domains (as measured by the 
CPT) at assessment I. MDD patients with remitted symp-
toms still showed significant deficits in executive function 
and motor function, but not in the memory or attention do-
mains at assessment II.
Discussion
  
 Our study demonstrated that remitted depressed pa-
tients with baseline cognitive impairment had experienced 
improvement in specific cognitive domains, i.e., memory as 
well as attention, and could reach the same performance lev-
els as the controls. This is consistent with a number of recent 
studies of major depression [7, 8]. This result echoed the 
findings of studies of elderly patients by Butters et al [11] 
and Beats et al [10]. In contrast, Neu et al assessed middle-
aged depressed patients with a melancholic subtype and re-
ported that after sustained remission [14], the patient group 
still performed significantly worse in verbal memory and 
verbal fluency compared to the controls. Other studies found 
persistent memory or attention dysfunction more often, and 
found these phenomena in older patients, mostly with en-
dogenous depression [2].
 The other finding in our study was that cognitive im-
pairment in the executive functioning and motor function-
ing domains persisted even after the depressed symptoms 
had recovered. This result adds to the body of evidence that 
MDD may yield some residual cognitive deficits even with 
successful treatment [5, 15]. Beats et al investigated elderly 
depressed patients on tests sensitive to frontal lobe dysfunc-
tion [10], and found that measures of simple and choice re-
action times, perseveration on the set-shifting task, and ver-
bal fluency did not fully recover. Nebes et al also found that 
decreased working memory and processing speed mediated 
cognitive impairment in elderly patients [12]. The process-
ing resource decrement persisted after remission of the de-
pression, and thus may be a trait marker of geriatric depres-
sion. Some authors suggest that working memory deficits 
in depression are due to persistent deficits in selective at-
tention (state-independence) have been related to persistent 
abnormalities in the prefrontal cortex [4, 15]. Furthermore, 
the findings across studies support the hypothesis that major 
depression is frequently associated with cognitive dysfunc-
tion and that the underlying defect is in the subcortical/fron-
tal lobe neural circuitry, i.e., the “frontostriatal dysfunction” 
[10, 22, 23]. However, studies that did find an association 
between lesions and cognitive function more often found this 
phenomenon in depressives, mostly with a late-onset of the 
illness [23-26]. Although microvascular pathology may ac-
count for the persistent cognitive impairment seen in elderly 
patients with depression [27], the contribution of such a pro-
cess to the residual cognitive impairment in younger depres-
sives remains uncertain. 
   In sum, our study implies that there might be a specific 
profile of cognitive deficits as stable vulnerability indica-
tors for MDD, and some other cognitive impairment may 
serve as state-dependent indicators for MDD. A generaliza-
tion of our results must be viewed with caution, considering 
the relatively small sample size. Clearly, further researches 
need to be undertaken with a larger sample size and more 
parameters to clarify the specific cognitive deficit of remitted 
MDD patients.
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